Found: 29
Select item for more details and to access through your institution.
Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 678, doi. 10.1002/ejhf.2488
- By:
- Publication type:
- Article
Clinical trials: conventional or pragmatic?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 596, doi. 10.1002/ejhf.2480
- By:
- Publication type:
- Article
The heart during iron deficiency: a non‐rechargeable battery?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 724, doi. 10.1002/ejhf.2479
- Publication type:
- Article
Autonomic dysregulation in diabetes: CAN we prevent heart failure?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 642, doi. 10.1002/ejhf.2476
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
Does left atrial deformation impact on symptoms and prognosis in functional mitral regurgitation patients with poor left ventricular function?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 705, doi. 10.1002/ejhf.2453
- By:
- Publication type:
- Article
The response to cardiac resynchronization therapy in LMNA cardiomyopathy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 685, doi. 10.1002/ejhf.2463
- By:
- Publication type:
- Article
Is it time to shift our focus from treatment to prevention of heart failure with a mineralocorticoid receptor antagonist?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 631, doi. 10.1002/ejhf.2459
- By:
- Publication type:
- Article
Corrigendum to 'Guidance on the management of left ventricular assist device (LVAD) supported patients for the non‐LVAD specialist healthcare provider: executive summary [Eur J Heart Fail 2021;23:1597–1609].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 733, doi. 10.1002/ejhf.2475
- Publication type:
- Article
Corrigendum to 'Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy' [Eur J Heart Fail 2021;23:854–871].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 732, doi. 10.1002/ejhf.2474
- Publication type:
- Article
Corrigendum to 'Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy' [Eur J Heart Fail 2021;23:527–540]
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 733, doi. 10.1002/ejhf.2473
- Publication type:
- Article
Corrigendum to 'Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry [Eur J Heart Fail 2021;23:1844–1854].
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 732, doi. 10.1002/ejhf.2472
- Publication type:
- Article
Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 603, doi. 10.1002/ejhf.2471
- By:
- Publication type:
- Article
Risk stratification in cardiogenic shock: from clinical utility to improving outcomes.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 668, doi. 10.1002/ejhf.2465
- By:
- Publication type:
- Article
Prioritizing prevention of de novo and worsening chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 653, doi. 10.1002/ejhf.2464
- By:
- Publication type:
- Article
The interplay between functional mitral regurgitation and left atrial function.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 703, doi. 10.1002/ejhf.2458
- By:
- Publication type:
- Article
Skeletal muscle alterations and exercise intolerance in heart failure with preserved ejection fraction patients: ultrasonography assessment of diaphragm and quadriceps.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 729, doi. 10.1002/ejhf.2462
- By:
- Publication type:
- Article
Screening‐guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at‐risk patients.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 620, doi. 10.1002/ejhf.2428
- By:
- Publication type:
- Article
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 708, doi. 10.1002/ejhf.2409
- By:
- Publication type:
- Article
How to calculate ventricular–arterial coupling?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 600, doi. 10.1002/ejhf.2456
- By:
- Publication type:
- Article
Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo <sup>31</sup>P magnetic resonance spectroscopy study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 716, doi. 10.1002/ejhf.2454
- By:
- Publication type:
- Article
Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause – the Cardiogenic Shock Score.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 657, doi. 10.1002/ejhf.2449
- By:
- Publication type:
- Article
Myocardial work and vascular dysfunction are partially improved at 12 months after COVID‐19 infection.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 727, doi. 10.1002/ejhf.2451
- By:
- Publication type:
- Article
Natriuretic peptide‐based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 672, doi. 10.1002/ejhf.2439
- By:
- Publication type:
- Article
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 681, doi. 10.1002/ejhf.2435
- By:
- Publication type:
- Article
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 634, doi. 10.1002/ejhf.2432
- By:
- Publication type:
- Article
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 645, doi. 10.1002/ejhf.2431
- By:
- Publication type:
- Article
Quantified mitral regurgitation and left atrial function in heart failure with reduced ejection fraction: interplay and outcome implications.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 694, doi. 10.1002/ejhf.2429
- By:
- Publication type:
- Article